Rescape is pioneering the use of VR to solve challenges in healthcare and frontline services. Their DR.VR platform launched in 2019 can help patients reduce pain and anxiety in hospitals and care homes. Their proprietary content and modular platform has already been sold to NHS hospitals and to Serco.
Imagine a world where hospitals can reduce their patients' pain & anxiety with less reliance on drugs. Where blue light workers not only learn empathy but feel it and develop strategies not only to cope but thrive. Rescape is building the VR content & platform that can help support this, using our shareable, single- & multi-user VR headset solutions.
The AR/VR in Healthcare Market is predicted to reach USD 30-40bn by 2026.
In 2019 we launched and validated DR.VR, selling a yearly licence directly to innovators in hospitals, hospices, care homes & trained prison custody officers for SERCO.
In 2021, our vision is to turn these healthcare innovators into early adopters. Evidence is key & 2 studies have already shown positive results for DR.VR. Now, collaborating with the Centre for Trials Research, Cardiff University we launched www.futureVISION.health.
In a new COVID-19 world, we believe that Rescape is well set to solve new healthcare challenges. By 2021 we aim to address infection control, explore grants, faster research & new product opportunities incl refining the platform & further research biofeedback with the AI opportunities it brings.
As an industry, there are over 20 years of clinical research with 1000's of studies showing the opportunities for healthcare. Rescape is building on this body of work and believe we are well placed to be at the centre of it in the UK & globally.